The Spineway Group has announced that it has signed an agreement to acquire Distimp. This marks the completion of the acquisition. In addition, Spineway has just begun the initiatives that will enable it to implement its growth strategy.
The Spineway Group has successfully completed the first stage of its external growth. The company has reached an agreement with Distimp allowing it todefinitively acquirethe French player in the sector of implants for spinal surgery. This acquisition will allow Spineway to hold 100% of Distimp's capital.
This acquisition is part of the group's objective to start implementing its growth strategy. Thanks to this acquisition, Spineway will be able to start expanding its product and service offering. This will be achieved by offering a wider range of implants and instruments.
These are intended for the treatment of severe spinal diseases. Also, Spineway plans to offer new high-value surgical techniques to surgeons. The acquisition will be financed entirely in cash.
In addition, following the transaction, Mr. Fabrice Paccagnella,President of Distimp, is expected to join the Spineway team. He will join the group as supervisor of the development and sales of the implant ranges of this new subsidiary.
Theacquisition of Distimp is very beneficial for Spineway. Indeed, this acquisition will enable the group to strengthen its commercial positions, particularly in France. To achieve this, the company will be able to rely on the large network of spine surgeons that Distimp will make available to it.
The transaction will also allow Spineway to benefit from the extensive experience ( over 25 years) of Distimp's President to increase its growth in the spine sector. It will also help the group to better meet the needs of its customers. It will enable the Group to offer its customers new solutions in the field of spine surgery.
Finally, this acquisition allows the company to mark an important step in its perspective to build a reference player in Europe in the spine sector. In addition, Distimp, for its part, expresses its satisfaction with its merger with Spineway. For his part, Fabrice Paccagnella says he is looking forward to working with the group's teams and making his know-how available.
Founded in 2005, Spineway is a French company specializing in the development of innovative implants for the treatment of severe spinal pathologies. The group focuses its activity on the design, manufacture and marketing of advanced surgical instruments, aiming to contribute effectively to the improvement of spinal therapy.
The company has a worldwide network of over 50 independent distributors. In addition, Spineway has a strong international presence. The group achieves about 90% of its turnover from exports. With more than 15 years of experience, it has a good reputation worldwide for its skills and technical expertise.